Optime Cares Patient-First Strategy Helps Physicians Optimize Care for Rare and Orphan Disease Patients with Pulmonary Issues During COVID-19 Pandemic | Financial Buzz

Optime Cares Patient-First Strategy Helps Physicians Optimize Care for Rare and Orphan Disease Patients with Pulmonary Issues During COVID-19 Pandemic

Optime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, points to the value of its patient-first approach and telehealth for addressing the unique healthcare coordination needs of patients with rare and orphan diseases during the COVID-19 pandemic. This is especially important for patients with Alpha-1 Antitrypsin Deficiency (Alpha-1), a genetic condition that may result in serious lung disease in adults and/or liver disease at any age.

“Many of these patients have been challenged to get much-needed support and education around their prescribed therapy and disease state, all while dealing with elevated stressors due to being immunocompromised, conscious of infection and hypersensitive to viral threats,” says Donovan Quill, president and CEO, Optime Care. “Optime Care’s patient-first approach offers patients a proactive, process-driven telehealth program which mitigates the transmission of infection, such as coronavirus, for these vulnerable individuals.”

Optime Care’s patient-first approach can ensure care continuity across the entire patient journey with robust communication to yield rich data that clinicians can use to make more informed decisions and improve the overall patient experience. This focus addresses all variables around collecting data, while maintaining frequent communication with patients and their families to ensure compliance and positive outcomes.

In a recent episode on the Rare Voices Podcast, Alpha-1 expert and front line COVID-19 physician Jeffrey Miskoff, DO, pulmonologist and critical care physician, provided insight on the importance of a patient-first program, discussed the impact telehealth can have moving forward, and gave a first-hand account on how a community physician can make a huge difference not just in the lives of COVID-19 and Alpha-1 patients, but all patients by having a patient-first mentality.

Listen to Optime Care’s Rare Voices podcast episode with Dr. Miskoff here.

Optime Care highlights the 2021 Virtual Alpha-1 National Conference, June 10-12, the largest annual gathering of Alphas, their families, leading healthcare professionals and industry professionals worldwide. This event emphasizes the importance of understanding this unique patient population by providing educational programs given by national experts and leaders in the Alpha-1 field and networking opportunities for patients diagnosed with Alpha-1, their families and industry and healthcare professionals, such as respiratory therapists, nurse practitioners, physicians and nurses.

About Optime Care

Optime Care, Inc. is a nationally recognized pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our management team has previously partnered in the launch and management of more than 40 orphan products and programs and consistently implemented the best brand programs for the community. Our experience with small patient populations makes us uniquely qualified to help every stakeholder group impacted by these disorders. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/

Contacts

Media:

Brittany Tedesco

CPR Communications

btedesco@cpronline.com

201.641.1911 x 14

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!